Products: Omidria

Web background


OMIDRIA® is the first and only FDA-approved drug that provides direct, continuous intracameral delivery of NSAID and mydriatic/anti-miotic therapy during cataract surgery.

OMIDRIA is FDA approved for addition to both BSS and BSS Plus - in contrast to compounded drugs and most other FDA-approved drugs that are not approved for administration in BSS or BSS Plus.

Indications and Usage

OMEDRIA is added to ophthalmic irrigation solution used during cataract surgery of intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.